Range
161.79 - 164.19
Vol / Avg.
13M/7.2M
Div / Yield
4.24/2.62%
52 Wk
133.65 - 173.65
Mkt Cap
426.9B
Payout Ratio
71.38
Open
163.27
P/E
28.62
EPS
2.35
Shares
2.6B
Outstanding
2.6B
Total Float
2.6B
Benzinga - 2 days ago
Benzinga - 3 days ago
Benzinga - 4 days ago
Benzinga - Jun 11, 2021, 9:06AM
Benzinga - Jun 10, 2021, 3:10PM
Benzinga - Jun 10, 2021, 3:09PM
Benzinga - Jun 9, 2021, 11:50AM
Benzinga - Jun 9, 2021, 11:49AM
Benzinga - Jun 1, 2021, 2:15PM
Benzinga - Jun 1, 2021, 2:06PM
Benzinga - Jun 1, 2021, 10:28AM
Benzinga - Jun 1, 2021, 9:39AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-21
REV
Q1 2021Est.ActualSurprise
EPS2.3402.590 0.2500
REV22.010B22.321B311.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
JNJJohnson & Johnson-1.88%426.9B

Johnson & Johnson Frequently Asked Questions

Q

How do I buy Johnson & Johnson (JNJ) stock?

A

You can purchase shares of Johnson & Johnson (NYSE: JNJ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Johnson & Johnson's (JNJ) competitors?

A

Other companies in Johnson & Johnson’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Johnson & Johnson (JNJ) stock?

A

The latest price target for Johnson & Johnson (NYSE: JNJ) was reported by Raymond James on January 27, 2021. The analyst firm set a price target for 183.00 expecting JNJ to rise to within 12 months (a possible 12.89% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Johnson & Johnson (JNJ)?

A

The stock price for Johnson & Johnson (NYSE: JNJ) is $162.11 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Johnson & Johnson (JNJ) pay a dividend?

A

There are no upcoming dividends for Johnson & Johnson. The last dividend paid out to investors was $0.03 on May 24, 2021.

Q

When is Johnson & Johnson (NYSE:JNJ) reporting earnings?

A
Johnson & Johnson’s Q2 earnings are confirmed for after-market on July 21, 2021.
Q

Is Johnson & Johnson (JNJ) going to split?

A

There is no upcoming split for Johnson & Johnson.

Q

What sector and industry does Johnson & Johnson (JNJ) operate in?

A

Johnson & Johnson is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.